|
C9ORF72 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.08270004073319E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02699999615652E-08 |
| Normal-vs-Stage2 |
1.06709974190267E-10 |
| Normal-vs-Stage3 |
1.3040000190756E-09 |
| Normal-vs-Stage4 |
1.00490005205955E-09 |
| Stage1-vs-Stage2 |
7.022200E-03 |
| Stage1-vs-Stage3 |
1.979440E-01 |
| Stage1-vs-Stage4 |
1.173840E-01 |
| Stage2-vs-Stage3 |
1.120560E-01 |
| Stage2-vs-Stage4 |
2.192600E-01 |
| Stage3-vs-Stage4 |
7.441800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.38580000200272E-09 |
| Normal-vs-AfricanAmerican |
2.782400E-03 |
| Normal-vs-Asian |
3.02829999965226E-07 |
| Caucasian-vs-AfricanAmerican |
9.334300E-02 |
| Caucasian-vs-Asian |
9.824000E-01 |
| AfricanAmerican-vs-Asian |
1.877000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43900000196362E-09 |
| Normal-vs-Female |
1.39889999584142E-09 |
| Male-vs-Female |
8.659800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.99799999878181E-08 |
| Normal-vs-Age(41-60Yrs) |
2.59770005506255E-09 |
| Normal-vs-Age(61-80Yrs) |
5.31770183442859E-11 |
| Normal-vs-Age(81-100Yrs) |
1.395950E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.932400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.397880E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.212000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.023600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.840200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.588000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.681860E-02 |
| Classical-VS-Follicular |
3.002700E-03 |
| Classical-VS-Other |
3.446600E-01 |
| Classical-VS-Normal |
5.35709999693879E-08 |
| Tall-VS-Follicular |
7.525200E-01 |
| Tall-VS-Other |
1.680000E-01 |
| Tall-VS-Normal |
8.23400014837716E-10 |
| Follicular-VS-Other |
6.781600E-02 |
| Follicular-VS-Normal |
1.64590008289167E-10 |
| Other-VS-Normal |
1.041990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.83749748328933E-11 |
| Normal-vs-N1 |
2.21339999995074E-07 |
| N0-vs-N1 |
1.704780E-01 |
|
|
